Samer O. Abdul‐Hay

Author

Samer O. Abdul‐Hay

Also Known As

S. Abdul-Hay, Samer Abdul-Hay, Samer Abdul‐Hay, Samer O Abdul-Hay, Samer O. Abdul-Hay, Samer O. Abdul‐Hay, Samer. Abdul-Hay (7958078)

Publications

788

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Florida University of Illinois Chicago Jacksonville College University of California, Irvine Boston University

About

Samer O. Abdul‐Hay is an author at Mayo Clinic in Florida specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	179
2	Natural Sciences	4	4	134
3	Biochemistry	4	4	134
4	Health Sciences	1	1	14
5	Cell Biology	1	1	22

Samer O. Abdul‐Hay

Publications

785

Citations

H-Index

Page 1

	Year	Citations
Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance Samer O. Abdul‐Hay, Dongcheul Kang, Melinda McBride, PLoS ONE	2011	117
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin Malcolm A. Leissring, E. Malito, Sabrine Hédouin, PLoS ONE	2010	106
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease Christopher W Medway, Samer O. Abdul‐Hay, Tynickwa Mims, Molecular Neurodegeneration	2014	81
Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40 Caitlin N. Suire, Samer O. Abdul‐Hay, Tomoko Sahara, Alzheimer s Research & Therapy	2020	74
Identification of BACE2 as an avid ß-amyloid-degrading protease Samer O. Abdul‐Hay, Tomoko Sahara, Melinda McBride, Molecular Neurodegeneration	2012	64
Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity Samer O. Abdul‐Hay, Amy L. Lane, Thomas R. Caulfield, Journal of Medicinal Chemistry Good PotencyPeptide ScienceInsulin-degrading Enzyme RevealsPeptide HydroxamatesChemical Biology	2013	60
Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates Isaac T. Schiefer, Samer O. Abdul‐Hay, Huali Wang, Journal of Medicinal Chemistry Intact Nitrate DrugTheir Hybrid NitratesNeurochemical BiomarkersPharmacotherapyHybrid Nitrates	2011	32
Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: In vitro evidence querying the NO donor functionality Tareisha L. Dunlap, Samer O. Abdul‐Hay, R. Esala P. Chandrasena, Nitric Oxide No Donor FunctionalityOncologyChemoprevention StrategyReactive Nitrogen SpecieMedicine	2008	31
Characterization of Insulin Degrading Enzyme and Other Amyloid-β Degrading Proteases in Human Serum: A Role in Alzheimer's Disease? Zhiheng Liu, Haihao Zhu, Guang Fang, Journal of Alzheimer s Disease	2012	30
Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors Samer O. Abdul‐Hay, Thomas D. Bannister, Hui Wang, ACS Chemical Biology	2015	27

Page 1